Literature DB >> 19373143

The distribution of brown recluse spiders in the southeastern quadrant of the United States in relation to loxoscelism diagnoses.

Richard S Vetter1.   

Abstract

The southern and eastern margins of the range of the brown recluse spider run through the southeastern quadrant of the United States. Populations vary from abundant in states such as Arkansas and west and central Kentucky and Tennessee to absent in the Atlantic seaboard states. The diagnosis of loxoscelism should be restricted to areas of the southeastern United States where brown recluse spiders are both common and widespread. Better knowledge of the local presence of recluse spiders in one's area, along with the list of differential diagnoses for dermonecrosis, will allow medical personnel in the south to better assess the probability of spider involvement in a necrotic skin lesion. In North America, there are two groups of spiders proven to be medically important: the widow spiders (genus Latrodectus) and the recluse spiders (genus Loxosceles). The widow spiders are a known entity, because their distinctive coloration makes them readily identifiable by nonarachnologists. Also, the physiological mechanism of the venom, the antivenom to counter it, and the symptoms are known, causing misdiagnosis to rarely occur. In contrast, recluse spiders are almost at the other end of the spectrum. They are readily misidentified or confused with harmless spiders, and the physiological mechanism of the venom is still being elucidated. Furthermore, no antivenom is commercially available, and the brown recluse's infamy causes many skin lesions of nonarachnid origin to be misdiagnosed as brown recluse spider bites.

Entities:  

Mesh:

Year:  2009        PMID: 19373143     DOI: 10.1097/SMJ.0b013e3181a0abb3

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  Catalogue of Texas spiders.

Authors:  David Allen Dean
Journal:  Zookeys       Date:  2016-03-02       Impact factor: 1.546

2.  Diethyl Azelate for the Treatment of Brown Recluse Spider Bite, a Neglected Orphan Indication.

Authors:  Robert T Streeper; Elzbieta Izbicka
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

3.  First report of brown widow spider sightings in Peninsular Malaysia and notes on its global distribution.

Authors:  Mustakiza Muslimin; John-James Wilson; Amir-Ridhwan M Ghazali; Kamil A Braima; John Jeffery; Fitri Wan-Nor; Mohamed E Alaa-Eldin; Siti-Waheeda Mohd-Zin; Wan S Wan-Yusoff; Yusoff Norma-Rashid; Yee L Lau; Mahmud Rohela; Noraishah M Abdul-Aziz
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-05-09

4.  Defining the complex phenotype of severe systemic loxoscelism using a large electronic health record cohort.

Authors:  Jamie R Robinson; Vanessa E Kennedy; Youssef Doss; Lisa Bastarache; Joshua Denny; Jeremy L Warner
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

5.  Brown Recluse spider bite mediated hemolysis: clinical features, a possible role for complement inhibitor therapy, and reduced RBC surface glycophorin A as a potential biomarker of venom exposure.

Authors:  Eric A Gehrie; Hui Nian; Pampee P Young
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

Review 6.  Forty Years of the Description of Brown Spider Venom Phospholipases-D.

Authors:  Luiza Helena Gremski; Hanna Câmara da Justa; Thaís Pereira da Silva; Nayanne Louise Costacurta Polli; Bruno César Antunes; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2020-03-06       Impact factor: 4.546

7.  Brown Spiders' Phospholipases-D with Potential Therapeutic Applications: Functional Assessment of Mutant Isoforms.

Authors:  Thaís Pereira da Silva; Fernando Jacomini de Castro; Larissa Vuitika; Nayanne Louise Costacurta Polli; Bruno César Antunes; Marianna Bóia-Ferreira; João Carlos Minozzo; Ricardo Barros Mariutti; Fernando Hitomi Matsubara; Raghuvir Krishnaswamy Arni; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Luiza Helena Gremski; Silvio Sanches Veiga
Journal:  Biomedicines       Date:  2021-03-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.